Yazar "Tanrıverdi, Özgür" için Scopus İndeksli Yayınlar Koleksiyonu listeleme
-
Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung
Alkan, Ali; Cenikli, Utku; Uylas, Selcuk; Yilmaz, Mehmet; Cakir, Tumay; Cetinkaya, Halil; Tanrıverdi, Özgür (Sage Publications Ltd, 2020)Opsoclonus-myoclonus syndrome is a rare disease and traditionally described as "dancing eyes, dancing feet syndrome." It is characterized by opsoclonus (oscillations of the eyes in either horizontally or vertically) and ... -
Use of complementary and alternative medicine and quality of life of cancer patients who received chemotherapy in Turkey
Irmak, Zohre; Tanrıverdi, Özgür; Odemis, Hilal; Uysal, Derya Demir (Churchill Livingstone, 2019)Objectives: This study aims to evaluate the frequency of use of CAM therapies among cancer patients, the types of CAM therapies they used, the demographic and clinical factors affecting their tendency to use CAM therapies, ... -
A View from Young Oncologists on Clinical Trials in Turkey: Obstacles and Solution Proposals
Akman, Tulay; Tanrıverdi, Özgür; Öztürk, Mehmet Ali; Petekkaya, Ibrahim; Bakkal, Hakan; Sonmez, Ozlem U.; Abali, Huseyin (Akad Doktorlar Yayinevi, 2014)There is a new improvement in oncology nearly in every day as a result of preclinical or clinical. As the number of publication per capita, Turkey is far behind the other developed European countries. For example, the ... -
Weight loss at the time of diagnosis is not associated with prognosis in patients with advanced-stage non-small cell lung cancer
Şahin, Cem; Omar, Muhyettin; Tunca, Hasan; Kalemci, Serdar; Özşeker, Burak; Akbaba, Gülhan; Tanrıverdi, Özgür (Imprimatur Publications, 2015)Purpose: To investigate the prognostic value of weight loss before diagnosis in patients with advanced stage non-small cell lung cancer (NSCLC) treated with first-line chemotherapy. Methods: A total of 81 NSCLC patients ... -
Which tyrosine kinase inhibitor must we apply before? A case report of crizotinib-resistant patient with concomitant EGFR and EML4-ALK gene mutations
Çokmert, S.; Veral, A. ,; Akyürek, N.; Keçeci, S.D.; Sivrikoz, O.; Yılma, E.; Tanrıverdi, Özgür; Coşkun, U. (University of the West Indies, 2021)The concomitant epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) translocations in lung adenocancers are very rare scenarios. Until now, 42 cases described in the literature have all ... -
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
Alkan, Ali; Yaşar, Arzu; Güç, Zeynep Gülsüm; Gürbüz, Mustafa; Başoğlu, Tuğba; Göksu, Sema Sezgin; Şenler, Filiz Çay; Tanrıverdi, Özgür (Wiley, 2020)Objective Fear of cancer recurrence (FCR) is an important psychological trauma associated with reduction in the quality of life, disruptions in the level of adjustment, emotional distress and anxiety. The purpose of the ...